Market Tracker

05/03 5:16pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.25
Delayed Data
As of 3:59pm ET
 -0.57 / -6.46%
Today’s Change
5.57
Today|||52-Week Range
11.05
-23.54%
Year-to-Date

Today’s Trading

Previous close8.82
Today’s open8.65
Day’s range8.12 - 8.76
Volume2,234,500
Average volume (3 months)1,686,799
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,479.06%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales20.49
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-2.02-5.29%
ACORAcorda Therapeutics ...-1.50-5.52%
CXRXConcordia Healthcare...-0.09-0.34%
INVAInnoviva Inc-0.27-2.25%
Data as of 3:59pm ET, 05/03/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts